Crossref
Nitroreductase-Activated Nitrofurantoin Encapsulated in Cubosomes for Enhanced Breast Cancer Treatment
Pharmaceutical Sciences and Drug Design · 2026 · 6 (1) · 106-118
DOI: 10.51847/ojk9sriaaj ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von Fatima Zahra Amrani und 1 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amrani, F. Z., & Benali, Y. (2026). Nitroreductase-Activated Nitrofurantoin Encapsulated in Cubosomes for Enhanced Breast Cancer Treatment. Pharmaceutical Sciences and Drug Design, 6(1), 106-118. https://doi.org/10.51847/ojk9sriaaj
Vancouver
Amrani FZ, Benali Y. Nitroreductase-Activated Nitrofurantoin Encapsulated in Cubosomes for Enhanced Breast Cancer Treatment. Pharmaceutical Sciences and Drug Design. 2026;6(1):106-118. doi:10.51847/ojk9sriaaj
BibTeX
@article{Amrani2026,
author = {Amrani, Fatima Zahra and Benali, Youssef},
title = {Nitroreductase-Activated Nitrofurantoin Encapsulated in Cubosomes for Enhanced Breast Cancer Treatment},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2026},
volume = {6},
number = {1},
pages = {106--118},
doi = {10.51847/ojk9sriaaj}
}
EUVIMED